Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1988
Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants
R Bookstein, E Y Lee, H To, et al.
Science (New York, N.Y.)
|
December 16, 1988
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells
H J Huang, J K Yee, J Y Shew, et al.
Journal of Pediatric Ophthalmology and Strabismus
|
July 1, 1990
Characteristics of two new retinoblastoma cell lines: WERI-Rb24 and WERI-Rb27
T W Sery, E Y Lee, W H Lee, et al.
Oncogene
|
February 18, 1999
Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase
A M Morimoto, A E Berson, G H Fujii, et al.
Nature
|
October 15, 1987
The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
W H Lee, J Y Shew, F D Hong, et al.
Cytogenetics and Cell Genetics
|
January 1, 1993
Report and abstracts of the First International Workshop on Human Chromosome 8 Mapping. Vancouver, British Columbia, May 2-4, 1993
S Wood, K Ben Othmane, U S Bergerheim, et al.
Human Genetics
|
June 1, 1988
Human esterase D gene: complete cDNA sequence, genomic structure, and application in the genetic diagnosis of human retinoblastoma
L J Young, E Y Lee, H A To, et al.
Cancer Research
|
December 16, 1998
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis
M A Davies, Y Lu, T Sano, et al.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1994
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials
D G Bostwick, H B Burke, T M Wheeler, et al.
Cancer Research
|
June 11, 1998
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer
I W Cheney, D E Johnson, M T Vaillancourt, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1988
Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants
R Bookstein, E Y Lee, H To, et al.
Science (New York, N.Y.)
|
December 16, 1988
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells
H J Huang, J K Yee, J Y Shew, et al.
Journal of Pediatric Ophthalmology and Strabismus
|
July 1, 1990
Characteristics of two new retinoblastoma cell lines: WERI-Rb24 and WERI-Rb27
T W Sery, E Y Lee, W H Lee, et al.
Oncogene
|
February 18, 1999
Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase
A M Morimoto, A E Berson, G H Fujii, et al.
Nature
|
October 15, 1987
The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
W H Lee, J Y Shew, F D Hong, et al.
Cytogenetics and Cell Genetics
|
January 1, 1993
Report and abstracts of the First International Workshop on Human Chromosome 8 Mapping. Vancouver, British Columbia, May 2-4, 1993
S Wood, K Ben Othmane, U S Bergerheim, et al.
Human Genetics
|
June 1, 1988
Human esterase D gene: complete cDNA sequence, genomic structure, and application in the genetic diagnosis of human retinoblastoma
L J Young, E Y Lee, H A To, et al.
Cancer Research
|
December 16, 1998
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis
M A Davies, Y Lu, T Sano, et al.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1994
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials
D G Bostwick, H B Burke, T M Wheeler, et al.
Cancer Research
|
June 11, 1998
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer
I W Cheney, D E Johnson, M T Vaillancourt, et al.
Page
of 5